0.961
-0.049 (-4.85%)
-0.049 (-4.85%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moleculin Biotech Inc | MBRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.049 | -4.85% | 0.961 | 19:56:33 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.98 | 0.95 | 1.00 | 0.97 | 1.01 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.951 | 0.96 | 0.009 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,455 | 1,533,823 | $ 0.9759619 | $ 1,496,953 | 3,805,489 | 0.323 - 1.97 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:55:05 | formt | 250 | $ 0.961 | USD |
Moleculin Biotech Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 60.03M | 62.46M | 55.55M | $ - | $ - | -0.34 | -3.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 2.40% |
Moleculin Biotech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MBRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.8983 | 1.09 | 0.8605 | 0.9851689 | 3,538,446 | 0.0627 | 6.98% |
| 1 Month | 0.8011 | 1.09 | 0.772601 | 0.9006218 | 2,705,299 | 0.1599 | 19.96% |
| 3 Months | 0.77 | 1.22 | 0.6526 | 0.9116386 | 2,297,533 | 0.191 | 24.81% |
| 6 Months | 1.01 | 1.74 | 0.6526 | 1.03 | 2,514,771 | -0.049 | -4.85% |
| 1 Year | 0.97 | 1.97 | 0.323 | 1.08 | 3,190,293 | -0.009 | -0.93% |
| 3 Years | 1.87 | 3.34 | 0.323 | 1.35 | 1,555,427 | -0.909 | -48.61% |
| 5 Years | 8.99 | 9.58 | 0.323 | 1.53 | 1,286,746 | -8.03 | -89.31% |
Moleculin Biotech Description
| Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis. |
